References
- Nishimura K, Nishino J, Kouchi A, Nakamura N, Nakajima S, Yokoe I, et al. Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose. Mod Rheumatol. 2011;21(2):158–63.
- Ichinose K, Ida H, Kawakami A, Tsukada T, Ueki Y, Eguchi K, et al. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis. Inter Med. 2010;49(20):2211–8.
- Kohriyama K, Hiramatsu Y, Aoyama T. Efficacy of combination pulse therapy with methotrexate and mizoribine for patients with rheumatoid arthritis showing escape phenomenon to low-dose methotrexate therapy (in Japanese). Clin Rheumatol. 2003;15(3):227–34.
- Murai T, Arai K, Fujisawa J, Ito S. Efficacy and safety of combination pulse therapy with methotrexate and mizoribine in rheumatoid arthritis patients (in Japanese). Jpn J Joint Dis. 2009;28(1):21–7.
- Kasama T, Wakabayashi K, Odai T, Isozaki T, Matsunaga M, Yajima N, et al. Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate. Mod Rheumatol. 2009;19(4):395–400.
- Suzuki D, Kimoto O, Sawada J, Shimoyama K, Kawashima M, Mukai T, et al. The efficacy and safety of combination therapy with mizoribine and methotrexate for rheumatoid arthritis resistant methotrexate (in Japanese). Jpn J Clin Immunol. 2011;34(3):149–53.
- Ito S. Treatment for rheumatoid arthritis in elderly patients to be provided by orthopedic surgeons (in Japanese). Jpn J Joint Dis. 2008;27(1):39–50.
- Nakamura S, Tokugawa S, Nakase M, Sakinaga Y, Taniguchi D. Clinical study of mizoribine for rheumatoid arthritis in our hospital (in Japanese). Clin Rheumatol. 2011;23(3):168–72.
- Nishimura K, Itoh K, Kuga Y, Uchida S, Nishino J, Nakamura N, et al. Prevention of joint destruction in rheumatoid arthritis patients receiving combination methotrexate and mizoribine therapy: a two year, multicenter open-comparison study to methotrexate monotherapy. Prog Med. 2006;26(9):2163–72.
- Moriguchi M, Terai C, Koseki Y, Uesato M, Kamatani N. Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Mod Rheumatol. 2000;10(4):230–4.
- Sato H, Kuroda T, Tanabe N, Ajiro J, Wada S, Murakami S, et al. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Scand J Rheumatol. 2010;39(1):33–7.